Introduction
The flaviviruses are the sole members of the genus flavivirus of the family Flaviviridae (Westaway et al., 1985) . At present the group consists of 68 species, of which 48~ are mosquito-borne and are responsible for epidemics such as yellow fever (YF), Japanese encephalitis and dengue. Of the remainder of the group 27~ are tick-borne and 25~ have no proven arthropod vector. By serological analysis the viruses share common epitopes, but have been assigned to eight major subgroups (Calisher et al., 1989) .
YF virus, the prototype virus for the flavivirus family and the aetiological agent of YF, has decreased as a major public health problem since the introduction of live attenuated YF vaccines. The vaccines were developed from two distinct origins. The French neurotropic vaccine was derived by serial passage of the parent virus, the French viscerotropic virus, in mouse tissue (Mathis et al., 1928) . The second vaccine was derived from wild-type YF virus strain Asibi, isolated in Ghana in 1927. Following passage of Asibi in mouse tissue and subsequently in chick embryo tissue a variant virus was obtained after 176 passages and was designated 17D (Theiler & Smith, 1937) . Two major substrains of the vaccine strain 17D exist, namely the 17D-204 strains from the Asibi virus, which are presently at passage level 233 to 243 and the 17DD strains, currently at a passage 0000-9245 © 1990 SGM level between 286 and 288 (Barrett, 1987) .
A study of the changes in the genome between wildtype Asibi virus and its vaccine derivative 17D-204 (243 passages on from the parent), revealed 68 nucleotide and 32 amino acid changes, which represents a divergence in the two sequences of 0.63~ at the nucleotide level (Rice et al., 1985; Hahn et al., 1987) . A relatively high number of amino acid changes were found to occur on the envelope glycoprotein and the authors concluded that such differences could be responsible for the reduced viscerotropism displayed by the vaccine. At present the only other live attenuated flavivirus vaccine is that for Japanese encephalitis. A wild-type strain, SA14, was passaged approximately 120 times in primary hamster kidney cells to produce a variant clone, designated 14-2, which is currently undergoing vaccine trials in China (Yu et al., 1988) .
Both of the above live attenuated flavivirus vaccines were derived after prolonged passage in cell culture. As several other flaviviruses are major pathogens the need for vaccines against these virus diseases is also important. However, the prospect of prolonged cellular passage of virus in the hope of producing a live attenuated, yet immunogenic virus is daunting and alternative methods are desirable.
In 1963 it was demonstrated that, after only six sequential HeLa cell passages of wild-type YF virus strain Asibi, the virus had lost its ability to cause viscerotropic disease in monkeys (Hardy, 1963) . In contrast, the 17D virus for use in YF vaccines was first shown to have a lowered viscerotropism after 176 passages in whole and minced chick embryo (Theiler & Smith, 1937) . The original work was later confirmed and extended (Hearn et al., 1965; Converse et al., 1971) . Since these studies some 20 years ago very little work has been done on the effect of passage of flaviviruses in HeLa cells. In this paper we report on the effects of six sequential HeLa cell passages on other members of the Flaviviridae. The results show that attenuation by HeLa cell passage is not unique to the Asibi strain of YF virus.
Methods
Virus strains. Three isolates of the mosquito-borne West Nile (WN) virus were used. These viruses consisted of the prototype Smithburn strain (a Ugandan isolate), an Egyptian isolate (Egypt 101) and a Malaysian isolate (Sarawak). WN-Sarawak had received only two mouse brain passages since its original isolation, whereas strains Smithburn and E 101 had received multiple passages in the laboratory. The tick-borne viruses used were louping-ill (LI) strain ADRI/3 from sheep brains (from Oban, U.K.) and Langat strain TP21 (LGT) from Malaysia.
Cells and virus.
HeLa cells were grown to monolayers in Eagle's minimal essential medium (EMEM; Flow Laboratories) containing 10 % foetal calf serum (FCS, Seralab). HeLa cells were seeded into 25 cm 2 flasks (Nunc) for the first four passages, then passages 5 and 6 were carried out in 80 cm z flasks (Nunc). Prior to infection with virus the monolayers were washed with phosphate-buffered saline (PBS) and infected with virus at an m.o.i, of between 1 and 5 p.f.u. After a 30 min adsorption EMEM containing 2% FCS was added and flasks were incubated at 37 °C for up to 3 days.
Infectivity titrations. Infectivity was determined by both plaque assay and TCIDs0. Plaque assays were performed on both adult rhesus monkey kidney (LLC-MK2) cells and HeLa cells that had been seeded in six-well plastic dishes (Nunc). Tenfold dilutions of virus were prepared in PBS, 0.1 ml samples were inoculated per well and allowed to adsorb for 30 min at room temperature. The monolayers were then covered with 5 ml of 1% Noble agar (Sigma) in EMEM supplemented with 2% FCS. Viral plaques were visualized after 4 days by staining with neutral red (Barrett et al., 1989) . TCIDso assays were made using HeLa cells. The cells were seeded into 24-well plastic dishes (Nunc) and allowed to grow to 80% confluence. Before infection the cell growth medium was removed and the cell sheet washed in PBS. Tenfold dilutions of the virus were made in PBS and 0.1 ml was added to the appropriate well. After 30 min of adsorption at room temperature 1 ml of EMEM supplemented with 2% FCS was added. The plates were incubated at 37 °C and examined daily for the appearance of c.p.e. When c.p.e, was present, or at day 4 post-infection (whichever was earlier), the cell sheet was fixed with 0-5 ml of 10% formaldehyde solution and then stained with 0.25% crystal violet solution. The endpoint for the assay was determined visually as 50% destruction of the cell monolayer.
Antigenic analysis using monoclonal antibody. Both parent and HeLa passage 6 (p6) viruses were tested in plaque reduction neutralization tests, which were carried out on LLC-MK2 monolayers, as described in Barrett et al. (1989) .
Temperature sensitivity study. Virus infectivity was measured by a plaque assay on LLC-MK2 cells as described above at 31, 35, 37, or 39-5 °C for the requisite number of days, before staining with neutral red and visualization of plaques.
Pathogenesis study. Female outbred (strain TO) white mice, 4 to 5 weeks old and weighing approximately 20 to 25 g were used. Mice were inoculated with virus diluted in PBS by one of three routes: intraperitoneally (i.p.) by inoculation of 100 ixl of virus, intranasally (i.n.) by placing 20 ~tl of virus dilution on the nostrils of a partially anaesthetized mouse or intracerebrally (i.c.) by inoculation of approximately 20 ~tl of virus. Average survival times and p.f.u./LDso were calculated where appropriate.
Suckling mice were inoculated by the i.c. route with virus diluted 1/10 with PBS. The mice were observed for 21 days before being weighed. The average weight of the mice was calculated and the standard error of the mean calculated, the results being compared to control mock-infected mice.
Results

Passage of virus through HeLa cells
Virus was harvested on or before day 3 post-infection, depending on the degree of c.p.e, exhibited by the virus. Virus infectivity at each passage was determined by plaque assays in LLC-MK2 cells and a TCIDs0 assay on HeLa cells, as HeLa cell plaque assays were unreliable (data not shown). The results are shown in Table 1 .
The WN strain Sarawak did not show c.p.e, in HeLa cells until passage 4 (see Table 1 ). The lack of c.p.e, was accompanied by an inability to detect virus by LLC-MK2 plaque assay from passages 1 to 4. However, low levels of virus could be detected at each passage level by a TCIDs0 test on HeLa cells. The appearance of c.p.e. following four HeLa cell passages of WN strain Sarawak coincided with the detection of high levels of virus by the LLC-MK2 plaque assay.
WN virus strains Egypt 101 and Smithburn (Table 1 ) and the tick-borne viruses LI and LGT (Table 1) all gave c.p.e, in HeLa cells throughout the six passages. In most cases the monolayer was destroyed before 3 days and often by 18 h post-infection. In the case of LI virus, despite the rapid appearance of c.p.e., the virus titre at passage six, as detected by plaque assay, was considerably lower than that of WN virus strain Sarawak and the tick-borne virus LGT.
After six HeLa passages WN strains Egypt 101 and Smithburn had lost their ability to infect the LLC-MK2 cells, as determined by plaque assay. Attempts to plaque the virus at the intermediate passage levels were also unsuccessful, plaques being detectable only with the nonHeLa-passaged parent viruses. Each passage was tested by plaque assay on Vero cells, another monkey kidney cell line often used to plaque flaviviruses, but without success. Assays of virus using HeLa cells in a TCIDso assay showed the presence of virus to a reasonable titre (104 p.f.u./ml) at the lower passage levels, but dropping towards passage 6 (102 p.f.u./ml). It was observed that there was a significant reduction in the titre of the virus following a single HeLa passage. This reduction was particularly marked for LI virus following a single HeLa passage (Table 1) .
Virulence of WN virus for mice following i.n. or i.p. inoculation
Groups of eight mice were inoculated either i.n. or i.p. with virus and observed over a maximum period of 21 days. The results show a variation in virulence between the viruses and also parent and p6 viruses (Table 2) . Six sequential HeLa cell passages of WN strain Sarawak resulted in significant attenuation of the virus. The p.f.u./LDs0 ratio of non-HeLa-passaged virus was 10 °'8 for i.p. inoculation and 100.5 for i.n. inoculation of adult mice. After six HeLa cell passages the p.f.u./LD50 was 104.4 following i.p. inoculation and 103.8 following i.n. inoculation. Thus, the HeLa p6 virus was attenuated approximately 4000-fold. WN virus strains Egypt 101 and Smithburn were very similar to each other after passage of the virus in HeLa cells. The infectivity titre of viruses present after six HeLa passages was relatively low (Table 1) . Following either i.p. or i.c. inoculation of adult mice the viruses proved to be totally avirulent (i.e. no mice died). However, the i.c. inoculated mice were hyperactive before they became sick between days 4 and 7 postinoculation, after which they survived the test period. In contrast the control mice died after inoculation of nonHeLa-passaged virus (data not shown).
WN-Sarawak HeLa p4 and p5 were also inoculated into mice to determine their pathogenicity. WNSarawak HeLa p4 appeared to be as virulent as the parent with no significant alteration in the p.f.u./LD5o of the virus (Table 2) . Following the fifth HeLa passage the virus exhibited a moderate degree of attenuation, but was still significantly more virulent than the HeLa p6 virus (Table 2) . However, the average survival time of mice inoculated with either the parent or HeLa passage 4, 5, or 6 viruses remained unchanged (approximately 8.2 days). It was considered possible that the HeLa p6 virus was not homogeneous and may have consisted of a population of viruses differing in pathogenicity, with the more virulent viruses being implicated with the disease seen in the mice. To test this hypothesis adult mice were inoculated i.p. with WN-Sarawak HeLa p6 virus and monitored until they became sick, at which time the animals were sacrificed and their brains removed. The brains were homogenized and their infectivity was titrated by plaque assay. All four brains examined contained large amounts of virus (108 p.f.u./ml), but the plaque morphology was the same as with the HeLa p6 viruses. The brain-derived viruses were reinoculated i.p. into adult mice and the average survival time and p.f.u./LDs0 ratio were calculated. Table 2 shows that there was no significant difference in the average survival time and LDs0 between the brain-derived virus ~nd the HeLa p6 virus initially used to inoculate the 1: ice.
Pathogenicity of WN virus strains Egypt 101 and Smithburn Jbr suckling mice
Following the demonstration of the avirulence of HeLapassaged WN virus strains El01 and Smithburn for 28 day old mice, the viruses were inoculated i.c. into 1 day old suckling mice, this being the most sensitive animal model available for the detection of infectious virus. The infected mice became sick between days 4 and 16 postinfection, with a significant lack of movement and response to touch in comparison to the mock-infected controls. No infectious virus detectable by plaque assay was found in brains sampled from mice at day 8 postinfection. By day 21 post-infection the control mockinfected mice had grown and were developing with no apparent effects from the inoculation, whereas the virusinfected mice were significantly runted and visually appeared sick, although the animals moved freely. The WN virus Egypt 101-infected mice were approximately 43 % lighter and the Smithburn mice 28 ~o lighter than the mock-infected mice (Table 3) .
Pathogenicity of the tick-borne viruses LI and LGT
LI and LGT remained as virulent for mice after six HeLa cell passages as the respective parent virus, with no mice surviving challenge with the HeLa-passaged virus. No alteration in average survival time was observed for the parent or p6 viruses (Table 4) .
Monoclonal antibody (MAb) reactivity
MAbs were used to determine changes in epitopes on the envelope protein of both the parent and HeLa p6 viruses. MAb Cll (prepared against Japanese encephalitis virus; J. X. Cao et al., unpublished observations) was found to be particularly interesting with respect to WN-Sarawak virus because it was very effective in neutralizing the parent virus (> 5 log10), but not the virus that had received 6 HeLa cell passages. Examination of WN-Sarawak HeLa p4 and p5 with MAb Cll showed that at HeLa p4 the virus was effectively neutralized by C11, whereas at HeLa p5 the virus was no longer neutralized by the MAb. The brainderived WN-Sarawak HeLa p6 virus remained nonreactive for C 11, as did the non-brain-passaged HeLa p6 virus (data not shown). LI virus was not recognized by MAb C11.
The tick-borne virus LGT was also neutralized by MAb Cll and reactivity of the virus with MAb Cll remained after 6 HeLa passages, with the virus being effectively neutralized (data not shown).
Temperature sensitivity of HeLa-and non-HeLa-passaged virus
The temperature sensitivity of both HeLa-and nonHeLa-passaged virus was examined by growth at 31, 35, 37 and 39.5 °C. Due to the inability of WN strains El01 and Smithburn to form plaques on LLC-MK2 cells the study was limited to WN strain Sarawak and the tickborne viruses.
Although WN strain Sarawak p0 grew throughout the temperature range, W N-Sarawak HeLa p6 was sensitive at the superoptimal temperature of 39-5 °C (Table 5 ). In comparison to the parent virus, the HeLa p6 virus showed a 4 log10 reduction in titre, as determined by LLC-MK2 plaque assay. In order to confirm the differences observed, the efficiency of plating was calculated (Table 5 ). In contrast to WN-Sarawak HeLa p6, the HeLa p4 and p5 viruses were found not to be temperature-sensitive. The two tick-borne viruses, which showed no attenuation following HeLa cell passage, were found to be non-temperature-sensitive.
Discussion
In 1963 Hardy demonstrated that, following six passages in HeLa cells, the prototype flavivirus YF strain Asibi exhibited a lowered viscerotropism for monkeys. This observation was later confirmed and extended (Hearn et al., 1965 (Hearn et al., , 1966 Converse et al., 1971) . This paper reports the effects of six HeLa cell passages on other members of the Flaviviridae. Both mosquito-and tick-borne viruses were examined to see whether they showed similar variation in virulence following HeLa passage. WNSarawak became attenuated after 5 HeLa passages and highly attenuated after 6 passages. Two other WN strains also became attenuated on passage, but their higher p.f.u./LD50 ratio made a quantitative analysis more difficult (data not shown). An interesting point was that, although the virus at HeLa p6 was attenuated by such a degree, the average survival time of the mice remained unchanged. It would therefore appear likely that there has been no alteration in the neuroinvasiveness of the HeLa-passaged virus, as determined by the average survival time. However, further studies would be required to substantiate this possibility.
WN strains Egypt t01 and Smithburn viruses were shown to be totally avirulent for both adult and suckling mice. However, the viruses did infect suckling mice and apparently caused defects in their growth, with the mice being recorded as runted. Presumably the differences seen between WN strains Sarawak, Smithburn and Egypt 101 on passage in HeLa cells relate to the different origins of the isolates. Another possible reason for variation in the pathogenicity results may be the generation of defective interfering particles after passaging of the virus at a high m.o.i. (Barrett & Dimmock, 1986) . However, whereas defective interfering particles can be readily produced by passage of virus at a high m.o.i, in most cell lines, generation of such particles in HeLa cells is particularly difficult (Stark & Kennedy, 1978) . It was possible that the virus population at passage 6 is not homogeneous and that virulent virus exists in the population. This was examined in two ways. Firstly, the viruses were purified by plaque picking and considered to represent a homogeneous population of virions before passage in HeLa ceils. Secondly, studies of WN-Sarawak HeLa p6 after mouse brain passage showed that the virus had maintained its attenuated state when reintroduced into mice. We can therefore conclude that the p6 virus population does not contain a major virulent subpopulation and the changes that have occurred at the genome level and confer attenuation would appear to be stable for at least one mouse brain passage.
In contrast to the attenuation of the mosquito-borne WN viruses, the two tick-borne viruses LI and LGT remained as virulent as the parent viruses for adult mice, even after six HeLa cell passages. This suggests that there may be a fundamental difference between mosquito-and tick-borne viruses that governs the way in which the virus interacts with the cell during replication. Alternatively, tick-borne flaviviruses may require more passages in HeLa cells before attenuation for mice is observed.
Attenuation by passage in HeLa cells was accompanied by antigenic changes on the envelope protein of the virus, as determined by MAbs. Very little change was observed between parent and HeLa-passaged viruses (data not shown). However, from the data with MAb C11, antigenic changes do occur on HeLa passage. Despite the loss of neutralizing capabilities of MAb C 11 with WN-Sarawak HeLa p6, the epitope recognized by MAb C11 was still present, as determined by indirect immunofluorescence.
In addition to the antigenic analysis with MAbs of envelope protein epitopes on the virus, WN-Sarawak was assayed for temperature sensitivity by incubation of the virus at sub-and superoptimal temperatures. The parent virus, not surprisingly, was permissive at all temperatures, yet after six HeLa cell passages the virus was sensitive at 39-5 °C. The virus titre was reduced by 4 log10 units at 39.5 °C, which is suggestive of a single As only six HeLa passages have been made it seems likely that either loss of MAb Cll reactivity, or appearance of temperature sensitivity, or a combination of both, may be responsible for the attenuation observed. Alternatively, it is possible that neither of these biological markers is involved and that their presence is merely coincidental. To test this hypothesis both WNSarawak HeLa p4 and p5 were tested for pathogenicity in mice. A number of interesting conclusions can be drawn from the results in Table 6 . Firstly, that the parent and HeLa p4 viruses are both virulent for mice, both are fully neutralized by MAb Cll and neither exhibits temperature-sensitive characteristics. Following five HeLa passages the neutralizing capacity of MAb C11 is lost, but the virus still replicates at all temperatures tested. The loss of MAb C11 reactivity is accompanied by an approximately 33-fold attenuation of the virus in comparison to the parent virus. After six HeLa passages the virus is again not neutralized by MAb C1 l, but is also temperature-sensitive. A 4000-fold attenuation of the virus is seen compared to the parent virus and a 12-fold difference over that of the p5 virus. It is therefore possible that both loss of neutralization by MAb C11 and the presence of temperature-sensitivity have an effect on virus virulence, with their contribution towards attenuation differing. Temperature sensitivity is associated with ~the greater attenuation and may be important to the attenuation of virulence seen after six HeLa passages of WN-Sarawak. We do not know the number or location of nucleotide and amino acid changes between nonHeLa-and HeLa-passaged WN virus, but with only six HeLa passages few changes would be anticipated. If this is true, results with MAb Cll indicate that there has been a change(s) on the envelope protein. It is of note that a proportion of the experimental dengue virus vaccines exhibit temperature sensitivity along with a small plaque morphology (Eckels et al., 1976) ; hence further characterization of this marker would be useful in determining its role in attenuation. In order to carry this out it will be necessary to obtain temperature-sensitive revertants and/or MAb Cll neutralization escape mutants and examine their role in the pathogenicity of WN virus for mice.
Flaviviruses are not the only viruses to have been attenuated by passage in HeLa cells. It has been shown that, following 65 HeLa cell passages, the alphavirus Venezuelan equine encephalitis virus showed a lowered pathogenicity for mice (Murphy et al., 1955) and it may be relevant that this virus, like WN virus, has a mosquito vector. The experiments described in this paper provide an excellent system with which to analyse the molecular basis of attenuation and virulence of flaviviruses. We are currently comparing parent and HeLa-passaged viruses to determine the molecular basis of attenuation of WN virus after passage in HeLa cells.
